The Safety, Efficacy, and Potential Complications of Intracameral Antibiotics

Ocular Microbiology and Immunology (B Jeng and L Schocket, Section Editors)
  • 7 Downloads
Part of the following topical collections:
  1. Topical Collection on Ocular Microbiology and Immunology

Abstract

Purpose of Review

The use of intracameral antibiotics (ICAs) as endophthalmitis prophylaxis after cataract surgery has increased in the past decade. The goal of this paper is to review the current literature arguing for and against ICAs.

Recent Findings

There is compelling evidence that ICAs have greater efficacy than topical antibiotics in preventing post-operative endophthalmitis. However, issues related to availability, cost, and safety have limited their widespread adoption in countries such as the USA.

Summary

In countries without access to a commercially available prepackaged antibiotic for intracameral use, cataract surgeons will have to individually weigh the risks and benefits of ICAs in determining their method of endophthalmitis prophylaxis.

Keywords

Intracameral antibiotics Cataract surgery Endophthalmitis Hemorrhagic occlusive retinal vasculitis 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

  1. 1.
    Garg P, Roy A, Sharma S. Endophthalmitis after cataract surgery: epidemiology, risk factors, and evidence on protection. Curr Opin Ophthalmol. 2017;28(1):67–72.  https://doi.org/10.1097/ICU.0000000000000326.CrossRefPubMedGoogle Scholar
  2. 2.
    Friling E, Lundstrom M, Stenevi U, Montan P. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg. 2013;39(1):15–21.  https://doi.org/10.1016/j.jcrs.2012.10.037.CrossRefPubMedGoogle Scholar
  3. 3.
    Grzybowski A, Kanclerz P, Myers WG. The use of povidone-iodine in ophthalmology. Curr Opin Ophthalmol. 2017;29:19–32.  https://doi.org/10.1097/ICU.0000000000000437. CrossRefGoogle Scholar
  4. 4.
    Grzybowski A, Kuklo P, Pieczynski J, Beiko G. A review of preoperative manoeuvres for prophylaxis of endophthalmitis in intraocular surgery: topical application of antibiotics, disinfectants, or both? Curr Opin Ophthalmol. 2016;27(1):9–23.  https://doi.org/10.1097/ICU.0000000000000216.CrossRefPubMedGoogle Scholar
  5. 5.
    Huang J, Wang X, Chen X, Song Q, Liu W, Lu L. Perioperative antibiotics to prevent acute endophthalmitis after ophthalmic surgery: a systematic review and meta-analysis. PLoS One. 2016;11(11):e0166141.  https://doi.org/10.1371/journal.pone.0166141.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Balestrazzi A, Malandrini A, Montagnani F, Nguisseu Chegoua GL, Ciompi L, Zanchi A, et al. Phacoemulsificator and sterile drapes contamination during cataract surgery: a microbiological study. Eur J Ophthalmol. 2012;22(2):188–94.  https://doi.org/10.5301/EJO.2011.8434.CrossRefPubMedGoogle Scholar
  7. 7.
    Endophthalmitis Study Group ESoC. Refractive S. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978–88.  https://doi.org/10.1016/j.jcrs.2007.02.032.CrossRefGoogle Scholar
  8. 8.
    Chang DF, Braga-Mele R, Henderson BA, Mamalis N, Vasavada A, Committee ACC. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2014 ASCRS member survey. J Cataract Refract Surg. 2015;41(6):1300–5.  https://doi.org/10.1016/j.jcrs.2015.01.014.CrossRefPubMedGoogle Scholar
  9. 9.
    Barry P. Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS Endophthalmitis Study. J Cataract Refract Surg. 2014;40(1):138–42.  https://doi.org/10.1016/j.jcrs.2013.11.002.CrossRefPubMedGoogle Scholar
  10. 10.
    Herrinton LJ, Shorstein NH, Paschal JF, Liu L, Contreras R, Winthrop KL, et al. Comparative effectiveness of antibiotic prophylaxis in cataract surgery. Ophthalmology. 2016;123(2):287–94.  https://doi.org/10.1016/j.ophtha.2015.08.039.CrossRefPubMedGoogle Scholar
  11. 11.
    Haripriya A, Chang DF, Namburar S, Smita A, Ravindran RD. Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at Aravind Eye Hospital. Ophthalmology. 2016;123(2):302–8.  https://doi.org/10.1016/j.ophtha.2015.09.037.CrossRefPubMedGoogle Scholar
  12. 12.
    Haripriya A, Chang DF, Ravindran RD. Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: analysis of 600 000 surgeries. Ophthalmology. 2017;124(6):768–75.  https://doi.org/10.1016/j.ophtha.2017.01.026.CrossRefPubMedGoogle Scholar
  13. 13.
    Cao H, Zhang L, Li L, Lo S. Risk factors for acute endophthalmitis following cataract surgery: a systematic review and meta-analysis. PLoS One. 2013;8(8):e71731.  https://doi.org/10.1371/journal.pone.0071731.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Kessel L, Flesner P, Andresen J, Erngaard D, Tendal B, Hjortdal J. Antibiotic prevention of postcataract endophthalmitis: a systematic review and meta-analysis. Acta Ophthalmol. 2015;93(4):303–17.  https://doi.org/10.1111/aos.12684.CrossRefPubMedGoogle Scholar
  15. 15.
    Linertova R, Abreu-Gonzalez R, Garcia-Perez L, Alonso-Plasencia M, Cordoves-Dorta LM, Abreu-Reyes JA, et al. Intracameral cefuroxime and moxifloxacin used as endophthalmitis prophylaxis after cataract surgery: systematic review of effectiveness and cost-effectiveness. Clin Ophthalmol. 2014;8:1515–22.  https://doi.org/10.2147/OPTH.S59776.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Naseri A, Melles RB, Shorstein NH. Intracameral antibiotics in the shadow of hemorrhagic occlusive retinal vasculitis. Ophthalmology. 2017;124(5):580–2.  https://doi.org/10.1016/j.ophtha.2017.02.019.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Schwartz SG, Grzybowski A, Flynn HW Jr. Antibiotic prophylaxis: different practice patterns within and outside the United States. Clin Ophthalmol. 2016;10:251–6.  https://doi.org/10.2147/OPTH.S100429.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Kim SJ, Toma HS. Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections. Ophthalmology. 2011;118(7):1358–63.  https://doi.org/10.1016/j.ophtha.2010.12.014.PubMedGoogle Scholar
  19. 19.
    Braga-Mele R, Chang DF, Henderson BA, Mamalis N, Talley-Rostov A, Vasavada A, et al. Intracameral antibiotics: safety, efficacy, and preparation. J Cataract Refract Surg. 2014;40(12):2134–42.  https://doi.org/10.1016/j.jcrs.2014.10.010.CrossRefPubMedGoogle Scholar
  20. 20.
    Nicholson LB, Kim BT, Jardon J, Townsend-Pico W, Santos C, Moshfeghi AA, et al. Severe bilateral ischemic retinal vasculitis following cataract surgery. Ophthalmic Surg Lasers Imaging Retina. 2014;45(4):338–42.  https://doi.org/10.3928/23258160-20140605-01.CrossRefPubMedGoogle Scholar
  21. 21.
    Witkin AJ, Chang DF, Jumper JM, Charles S, Eliott D, Hoffman RS, et al. Vancomycin-associated hemorrhagic occlusive retinal vasculitis: clinical characteristics of 36 eyes. Ophthalmology. 2017;124(5):583–95.  https://doi.org/10.1016/j.ophtha.2016.11.042.CrossRefPubMedGoogle Scholar
  22. 22.
    Administration USFD. Compounded Triamicinolone and Moxifloxacin Product for Intravitreal Injection by Guardian Pharmacy Services: Alert to Health Professionals - Serious Adverse Events Reported. 2017. https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm569123.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery. Accessed October 24th, 2017.
  23. 23.
    Administration USFD. A case of hemorrhagic occlusive retinal vasculitis (HORV) following intraocular injections of a compounded triamcinolone, moxifloxacin, and vancomycin formulation. https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm578514.htm. Accessed 7 February 2018.
  24. 24.
    Todorich B. New Insights in Vancomycin-associated Hemorrhagic Occlusive Retinal Vasculopathy (HORV). Retina Society Annual Meeting; Boston, MA October 5, 2017.Google Scholar
  25. 25.
    Arshinoff SA, Modabber M. Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis. J Cataract Refract Surg. 2016;42(12):1730–41.  https://doi.org/10.1016/j.jcrs.2016.10.017.CrossRefPubMedGoogle Scholar
  26. 26.
    Delyfer MN, Rougier MB, Leoni S, Zhang Q, Dalbon F, Colin J, et al. Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgery. J Cataract Refract Surg. 2011;37(2):271–8.  https://doi.org/10.1016/j.jcrs.2010.08.047.CrossRefPubMedGoogle Scholar
  27. 27.
    Cakir M, Imamoglu S, Cekic O, Bozkurt E, Alagoz N, Oksuz L, et al. An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery. Curr Eye Res. 2009;34(11):988–95.  https://doi.org/10.3109/02713680903254822.CrossRefPubMedGoogle Scholar
  28. 28.
    Mamalis N, Edelhauser HF, Dawson DG, Chew J, LeBoyer RM, Werner L. Toxic anterior segment syndrome. J Cataract Refract Surg. 2006;32(2):324–33.  https://doi.org/10.1016/j.jcrs.2006.01.065.CrossRefPubMedGoogle Scholar
  29. 29.
    Schwartz SG, Flynn HW Jr, Grzybowski A, Relhan N, Ferris FL 3rd. Intracameral antibiotics and cataract surgery: endophthalmitis rates, costs, and stewardship. Ophthalmology. 2016;123(7):1411–3.  https://doi.org/10.1016/j.ophtha.2016.03.024.CrossRefPubMedGoogle Scholar
  30. 30.
    O'Brien TP, Arshinoff SA, Mah FS. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. J Cataract Refract Surg. 2007;33(10):1790–800.  https://doi.org/10.1016/j.jcrs.2007.06.026.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Ophthalmology, Tufts Medical Center, New England Eye CenterBostonUSA

Personalised recommendations